Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

India Intravenous Solutions Market Outlook

The India intravenous solutions market size was valued at INR 171.44 billion in 2023, driven by its wide utility in various healthcare domains ranging from surgical to post-surgical care across the region. The market is expected to grow at a CAGR of 8.3% during the forecast period of 2024-2032, with the values likely to rise from INR 185.67 billion in 2024 to INR 351.37 billion by 2032.

Intravenous Solutions: Introduction

Intravenous solutions are injected into a patient’s vein to prevent or treat electrolyte imbalance or dehydration in the body. It is injected through an IV (intravenous) tube. It may be used to restore electrolytes in people who are suffering from diarrhea or vomiting, have exercised too much, have burns or serious injuries, or have undergone surgery. Intravenous solutions contain various nutrients. The three main types of intravenous solutions are hypotonic, isotonic, and hypertonic.

India Intravenous Solutions Market Analysis

The development of the healthcare infrastructure in the country is a key trend supporting the growth of the India intravenous solutions market value. With more hospitals and medical care centres available across the country, including in smaller towns, the demand for intravenous solutions is expected to rise. In addition, there is a heightened focus on providing apt neonatal care to decrease the infant mortality rate. As intravenous solutions provide instant effect, they have been widely adopted to treat malnutrition in infants, women as well as children in the region.

The rising prevalence of cancer is another factor contributing to the market growth. Treatments like radiation and chemotherapy also rely on intravenous solutions for efficient response.

Specific programs like the Rashtriya Kishor Swasthya Karyakram, Ayushman Bharat which includes PM-JAY, India’s biggest government sponsored health insurance scheme, along with the National Digital Health Mission have been initiated by the government to make the masses informed and empowered to make appropriate health decisions. There is another allocation INR 5,000 crore to boost the medical healthcare research and development in pharmaceutical sector. Moreover, with the integration of latest technologies like artificial intelligence and data analytics in medical ecosystem, we can expect the India intravenous solutions market share to expand globally as well.

India Intravenous Solutions Market Segmentation

Market Breakup by Type of Intravenous Solutions

  • Crystalloids
  • Colloids
  • Parenteral Nutrition Solutions
  • Blood-Derived Products
  • Others

Market Breakup by Application

  • Fluid Replacement Therapy
  • Electrolyte Imbalance Correction
  • Blood Transfusion
  • Parenteral Nutrition
  • Chemotherapy
  • Rehydration

Market Breakup by End-User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres
  • Home Healthcare Settings

India Intravenous Solutions Market Overview

India intravenous solutions market demand has observed a significant upswing, owing to their increased application in several healthcare conditions, including surgery, chemotherapy, blood transfusions as well as emergency medicines. This increased usage can be accredited to its relatively higher efficacy and rapid response capabilities to those in need. Moreover, the population dynamics of the region are quite diverse, ranging from pediatrics to geriatrics. Intravenous solutions, being easily accessible and affordable, are heavily used to cater to different dynamics.

India intravenous solutions market growth is driven by a diverse range of government as well as private sector initiatives to improve the healthcare system, build high-capacity hospitals and clinics for increasing population and facilitate better public health opportunities. In addition, there is high emphasis on inviting Foreign Direct Investment (FDI) with a vision to foster growth in the healthcare sector.

India Intravenous Solutions Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Fresenius SE & Co. KGaA
  • Piramal Enterprises Limited
  • Hospira (Pfizer Inc.)
  • Amsino International Inc.
  • ICU Medical, Inc.
  • Sami Labs Limited
  • Troikaa Pharmaceuticals Ltd.
  • Neiss Labs Pvt. Ltd.
  • Ketan Pharma
  • Abaris Healthcare Pvt. Ltd.
  • Parenteral Drugs (India) Ltd.
  • Arbro Pharmaceuticals Limited
  • Neon Laboratories Ltd.

Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type of Intravenous Solutions
  • Application
  • End-User
Breakup by Type of Intravenous Solutions
  • Crystalloids
  • Colloids
  • Parenteral Nutrition Solutions
  • Blood-Derived Products
  • Others
Breakup by Application
  • Fluid Replacement Therapy
  • Electrolyte Imbalance Correction
  • Blood Transfusion
  • Parenteral Nutrition
  • Chemotherapy
  • Rehydration
Breakup by End-User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres
  • Home Healthcare Settings
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Fresenius SE & Co. KGaA
  • Piramal Enterprises Limited
  • Hospira (Pfizer Inc.)
  • Amsino International Inc.
  • ICU Medical, Inc.
  • Sami Labs Limited
  • Troikaa Pharmaceuticals Ltd.
  • Neiss Labs Pvt. Ltd.
  • Ketan Pharma
  • Abaris Healthcare Pvt. Ltd.
  • Parenteral Drugs (India) Ltd.
  • Arbro Pharmaceuticals Limited
  • Neon Laboratories Ltd.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!

Key Questions Answered in the Report

The market attained a value of about INR 171.44 billion in 2023, driven by the increased application of intravenous solutions across several healthcare domains.

The market is expected to grow at a CAGR of 8.3% during the forecast period of 2024-2032, with the values likely to rise to INR 351.37 billion by 2032.

The high market demand is majorly driven by the ability of intravenous solutions to provide rapid response rate to patients, along with their higher efficacy and wider applications.

The current market trend revolves around increased government intervention and initiatives to offer quality healthcare services to the masses. Health initiatives like the Rashtriya Kishor Swasthya Karyakram, Ayushman Bharat and the National Digital Health Mission are some common examples set up by the Indian government.

Based on the type of intravenous solutions, the market is divided into crystalloids, colloids, parenteral nutrition solutions, and blood-derived products, among others. 

Common application include fluid replacement therapy, electrolyte imbalance correction, blood transfusion, parenteral nutrition, chemotherapy, and rehydration.

Major end users in the market include hospitals, clinics, ambulatory surgical centres, and home healthcare settings.

Key players involved in the market are Baxter International Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Piramal Enterprises Limited, Hospira (Pfizer Inc.), Amsino International Inc., ICU Medical, Inc., Sami Labs Limited, Troikaa Pharmaceuticals Ltd., Neiss Labs Pvt. Ltd., Ketan Pharma, Abaris Healthcare Pvt. Ltd., Parenteral Drugs (India) Ltd., Arbro Pharmaceuticals Limited and Neon Laboratories Ltd.

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Pricing Plans

Purchase Full Report

Datasheet

 

USD 2,199

USD 1,999

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 3,299

USD 2,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 4,399

USD 3,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Strategic Solutions for Informed Decision-Making

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124